159 results on '"Holvoet, Lieselot"'
Search Results
2. Efficacy of Mirtazapine in Patients With Functional Dyspepsia and Weight Loss
3. Tu1363: SYMPTOM CLUSTERS OUTSIDE THE ROME IV CONSENSUS CAN BE IDENTIFIED IN BOTH EASTERN AND WESTERN PATIENTS WITH A DISORDER OF GUT-BRAIN INTERACTION: PRELIMINARY RESULTS OF AN ONGOING INTERNATIONAL MULTICENTER STUDY
4. Botulinum Toxin Reduces Dysphagia in Patients With Nonachalasia Primary Esophageal Motility Disorders
5. A double-blind randomized, multicenter, placebo-controlled study of itopride in functional dyspepsia postprandial distress syndrome.
6. Baclofen Improves Symptoms and Reduces Postprandial Flow Events in Patients With Rumination and Supragastric Belching
7. A double‐blind randomized, multicenter, placebo‐controlled study of itopride in functional dyspepsia postprandial distress syndrome
8. Impact on aerosol generation during upper endoscopy of mouthpiece designed to reduce COVID-19 droplet spread: single-center randomized controlled trial
9. A survey of functional dyspepsia in 361,360 individuals: Phenotypic and genetic cross‐disease analyses
10. Efficacy of the Long-Acting Repeatable Formulation of the Somatostatin Analogue Octreotide in Postoperative Dumping
11. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism
12. A survey of functional dyspepsia in 361,360 individuals: Phenotypic and genetic cross‐disease analyses.
13. A multidimensional model of psychobiological interactions in functional dyspepsia: a structural equation modelling approach
14. Mo1106 PREVALENCE OF MEAL-RELATED GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH A DISORDER OF GUT-BRAIN INTERACTION
15. PSYCHOSOCIAL FACTORS ARE ASSOCIATED WITH A POSITIVE SYMPTOM ASSOCIATION DURING 24 HOUR IMPEDANCE-PH MONITORING IN GERD PATIENTS: C207.06
16. The effect of rikkunshito on gastrointestinal symptoms and gastric motor function: The first study in a Belgian functional dyspepsia population
17. Efficacy and safety of lanreotide in postoperative dumping syndrome: A Phase II randomised and placebo‐controlled study
18. Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study
19. Tu1309 – Effect of Rikkunshito on Gastrointestinal Motility and Upper Gastrointestinal Symptoms - the First Study in a Belgian Functional Dyspepsia Population
20. Impact on aerosol generation during upper endoscopy of mouthpiece designed to reduce COVID-19 droplet spread: single-center randomized controlled trial.
21. 383 - The Therapeutic Outcome of Itopride in Functional Dyspepsia Postprandial Distress Syndrome: A Double-Blind Randomized, Multicenter, Placebo-Controlled Study
22. The Impact of Rome IV Criteria on Functional Dyspepsia Subgroups in Secondary Care
23. The Waiting Room Questionnaire: Validation of a Novel Patient Reported Outcome Questionnaire for the Diagnosis of Functional Gastrointestinal Disorders
24. Sa1722 Validation of the Leuven Postprandial Distress Scale (LPDS), a Patient Reported Outcome Questionnaire for Symptom Assessment in Patients Suffering From Functional Dyspepsia / Postprandial Distress Syndrome
25. 1077 A Controlled Cross-Over Trial Shows Benefit of Prucalopride for Symptom Control and Gastric Emptying Enhancement in Idiopathic Gastroparesis
26. Associations between gastric sensorimotor function, depression, somatization, and symptom-based subgroups in functional gastroduodenal disorders: are all symptoms equal?
27. Factors associated with co-morbid irritable bowel syndrome and chronic fatigue-like symptoms in functional dyspepsia
28. Mo1665 - The Waiting Room Questionnaire: Validation of a Novel Patient Reported Outcome Questionnaire for the Diagnosis of Functional Gastrointestinal Disorders
29. Sa1610 - The Impact of Rome IV Criteria on Functional Dyspepsia Subgroups in Secondary Care
30. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism
31. Mo2066 Diazoxide, an Insulin Release Inhibitor, Improves Late Hypoglycemia in Dumping Syndrome
32. Mo2052 Functional Dyspepsia: Outcome of Focus Groups for the Development of a Questionnaire for Symptom Assessment in Patients Suffering From Postprandial Distress Syndrome (PDS)
33. Mo2062 Liraglutide, a Long-Acting GLP-1 Agonist, Improves Parameters of Late Dumping Syndrome During Ogtt in Patients Without Gastrectomy
34. Mo2051 Pasireotide, a Novel Somatostatin Analogue, in the Treatment of Postoperative Dumping Syndrome
35. 665 Gastric Sensitivity and Emptying Interact With Gastric Accommodation in Functional Dyspepsia
36. 161 Mirtazapine Improves Early Satiation, Nutrient Intake, Weight Recovery and Quality of Life in Functional Dyspepsia With Weight Loss: A Double-Blind, Randomized, Placebo-Controlled Pilot Study
37. 269 Acute Psychological Stress Increases Small Intestinal Permeability in Healthy Volunteers via CRH-Mediated Activation of Mast Cells
38. Mo2064 ROME III Functional Dyspepsia Subdivision in PDS and Eps: Recognizing Postprandial Symptoms Reduces Overlap
39. 572 Acute Anxiety and Chronic Co-Morbid Anxiety Impair Gastric Accommodation in Functional Dyspepsia
40. A multidimensional model of psychobiological interactions in functional dyspepsia: a structural equation modelling approach
41. 1122 Affective Disorders, Somatization and Body Awareness are Associated With Positive Symptom Association During 24 Hour Impedance-pH Monitoring in Patients With Reflux Symptoms
42. 137c Globus Patients are Characterized by Abnormal Sensitization of the Esophageal Body Upon Repeated Balloon Distensions
43. 312 Increased Regional Cerebral Type 1 Cannabinoid Receptor Availability in Functional Dyspepsia: A [18F]MK9470 PET Study
44. 430 Patient Characteristics Associated With Symptom Severity in Globus: Contributions of Both Esophageal Sensorimotor Function and Psychological Factors
45. Upper Esophageal Sphincter Compliance and ‘Somatization’ Are Independently Associated With Symptom Levels in Globus Patients
46. Determinants of Symptom Perception During Impedance-pH Monitoring: Do Psychosocial Factors and ‘Somatization’ Play a Role?
47. A Pilot Study on Duodenal Mucosal Integrity in Functional Dyspepsia
48. Associations Between Gastric Sensorimotor Function, Depression, ‘Somatization’ and Symptom-Based Subgroups in Functional Gastroduodenal Disorders: Are All Symptoms Equal?
49. Baclofen Improves Symptoms and Postprandial Flow Events in Patients With Rumination and Supragastric Belching/Aerophagia
50. Associations Between Patient Characteristics and GERD Symptoms: Are Psychosocial Factors and ‘Somatization’ More Important Than Reflux Parameters?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.